1. Home
  2. SABS vs KDLY Comparison

SABS vs KDLY Comparison

Compare SABS & KDLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • KDLY
  • Stock Information
  • Founded
  • SABS 2014
  • KDLY 2019
  • Country
  • SABS United States
  • KDLY United States
  • Employees
  • SABS N/A
  • KDLY N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • KDLY
  • Sector
  • SABS Health Care
  • KDLY
  • Exchange
  • SABS Nasdaq
  • KDLY NYSE
  • Market Cap
  • SABS 11.4M
  • KDLY 9.5M
  • IPO Year
  • SABS N/A
  • KDLY 2024
  • Fundamental
  • Price
  • SABS $1.75
  • KDLY $1.81
  • Analyst Decision
  • SABS Strong Buy
  • KDLY
  • Analyst Count
  • SABS 5
  • KDLY 0
  • Target Price
  • SABS $11.40
  • KDLY N/A
  • AVG Volume (30 Days)
  • SABS 25.4K
  • KDLY 78.1K
  • Earning Date
  • SABS 05-19-2025
  • KDLY 05-07-2025
  • Dividend Yield
  • SABS N/A
  • KDLY N/A
  • EPS Growth
  • SABS N/A
  • KDLY N/A
  • EPS
  • SABS N/A
  • KDLY N/A
  • Revenue
  • SABS $1,322,410.00
  • KDLY $2,719,840.00
  • Revenue This Year
  • SABS N/A
  • KDLY N/A
  • Revenue Next Year
  • SABS $50.00
  • KDLY N/A
  • P/E Ratio
  • SABS N/A
  • KDLY N/A
  • Revenue Growth
  • SABS N/A
  • KDLY N/A
  • 52 Week Low
  • SABS $1.00
  • KDLY $0.65
  • 52 Week High
  • SABS $5.01
  • KDLY $5.25
  • Technical
  • Relative Strength Index (RSI)
  • SABS 63.35
  • KDLY N/A
  • Support Level
  • SABS $1.30
  • KDLY N/A
  • Resistance Level
  • SABS $1.49
  • KDLY N/A
  • Average True Range (ATR)
  • SABS 0.14
  • KDLY 0.00
  • MACD
  • SABS 0.06
  • KDLY 0.00
  • Stochastic Oscillator
  • SABS 100.00
  • KDLY 0.00

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About KDLY KINDLY MD INC

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

Share on Social Networks: